Is the US prepared to deal with another pandemic or widespread health crisis?

No, the US is not fully prepared for another pandemic or widespread health crisis, though it has made meaningful improvements in specific areas since COVID-19. Significant gaps remain in leadership coordination, sustained funding, public health infrastructure, workforce, supply chains, trust, and equity that leave the country vulnerable.[1]

Improvements Since COVID-19

The US has strengthened certain technical and logistical capacities:

•Strategic National Stockpile (SNS): Greatly expanded, with reports of 70 times more N95 respirators, 34 times more gloves, 50 times more isolation gowns, and 10 times more ventilators compared to pre-pandemic levels. It has supported responses to H5N1, mpox, and other threats.[2]

•Surveillance and data systems: Electronic case reporting expanded dramatically (from fewer than 200 healthcare facilities in 2020 to over 45,000–48,000 by 2024). Syndromic surveillance covers most hospital emergency departments. New tools and forecasting (e.g., CDC’s Center for Forecasting and Outbreak Analytics) aid decision-making.[2]

•Institutional changes: The Office of Pandemic Preparedness and Response Policy (OPPR) was established in 2023 as a permanent White House office. Investments in R&D (including mRNA platforms and medical countermeasures), testing “warm bases,” and domestic manufacturing capacity have advanced. The Biden administration’s roadmap highlighted large-scale vaccination, testing, and treatment programs that saved lives.[2]

•International assessments: The US ranked at or near the top of the Global Health Security (GHS) Index (e.g., first in 2019 and high in 2021 editions), reflecting strong laboratory, detection, and norms capacities, though the index itself notes no country is fully prepared and scores do not guarantee effective response. A 2024 WHO Joint External Evaluation (JEE) of International Health Regulations capacities acknowledged progress while issuing recommendations.[3]

CDC and other agencies have implemented lessons on testing, partnerships, and response frameworks.[4]

Persistent Gaps and Vulnerabilities

Despite these advances, bipartisan and expert assessments describe the US as still dangerously underprepared:

•Leadership and coordination: Biodefense responsibilities are fragmented across 15+ federal departments/agencies and many congressional committees. The Bipartisan Commission on Biodefense’s 2024 National Blueprint for Biodefense stresses the need for sustained White House leadership (e.g., elevating the National Security Advisor’s role and creating a dedicated deputy), a quadrennial review process, and better interagency/SLTT (state, local, tribal, territorial) alignment. Turf battles and unclear authorities persist.[1]

•Detection and outdated systems: Tools like BioWatch (airborne pathogen detection) are widely criticized as ineffective after two decades. Gaps remain in integrating animal-human-environmental (One Health) surveillance and real-time data sharing.[5]

•Workforce, funding, and infrastructure: Public health departments face staffing shortages, burnout, and declining numbers. COVID-era investments (e.g., American Rescue Plan workforce funds) need sustained monitoring and follow-through. Many GAO recommendations from COVID reviews remain unimplemented. Funding is often reactive or subject to cuts/political shifts, risking “on-again/off-again” preparedness.[6]

•Supply chains, countermeasures, and equity: Vulnerabilities in pharmaceuticals, PPE, and manufacturing persist (though efforts like strategic API reserves are underway). Stockpiles of specific vaccines/treatments (e.g., for influenza or smallpox) may be insufficient for rapid nationwide scale-up. Disparities in access, health literacy, and outcomes for vulnerable populations remain. A National Academies report highlighted unreadiness for a smallpox outbreak (intentional, accidental, or otherwise).[7]

•Societal and political factors: Erosion of public trust, misinformation, polarization, and inconsistent messaging undermined the COVID response and complicate future efforts. H5N1 (avian influenza) circulation in US cattle has exposed coordination challenges between agriculture and health sectors, testing requirements, and farmer trust.[8]

•Broader lessons unlearned: Pre-COVID, the US ranked highly on paper (GHS Index) yet performed poorly in outcomes (high deaths relative to peers). Experts note that progress is fragile, uneven across states/localities, and that systemic issues (chronic underinvestment in public health, healthcare inequities, weak surge capacity) endure. Global efforts (Pandemic Fund, IHR amendments, potential agreements) help but depend on sustained US engagement.[6]

Bottom Line

The US has a strong scientific and economic foundation, better stockpiles, improved surveillance tech, and institutional reforms that make it more capable in certain domains than in early 2020. However, experts from the Bipartisan Commission on Biodefense, National Academies, GAO, former officials, and others consistently conclude that it is not adequately prepared for a major novel pathogen, engineered threat, or complex multi-hazard crisis. Success would require sustained bipartisan political will for leadership reforms, consistent funding, workforce rebuilding, supply chain resilience, community trust-building, and addressing inequities—areas where momentum has historically faded after crises.[1]

Preparedness is dynamic and threat-dependent (e.g., respiratory virus vs. something else). Ongoing monitoring of emerging threats like H5N1, continued investment, and implementation of outstanding recommendations would strengthen resilience. Without them, another widespread crisis risks repeating or exceeding COVID-era disruptions.

Citations (8)

1biodefensecommission.orgNonprofits and think tanks
https://biodefensecommission.org/reports/the-national-blueprint-for-biodefense/
Backs: “Significant gaps remain in leadership coordination, sustained funding, public health infrastructure, workforce, supply chains, trust, and equity that leave the country vulnerable.”
2archives.govGovernment
https://bidenwhitehouse.archives.gov/briefing-room/statements-releases/2025/01/14/report-the-biden-harris-administration-roadmap-for-pandemic-preparedness-and-response/
Backs: “It has supported responses to H5N1, mpox, and other threats.”
3wikipedia.orgEncyclopedias and referencequality 0.83
https://en.wikipedia.org/wiki/Global_Health_Security_Index
Backs: “A 2024 WHO Joint External Evaluation (JEE) of International Health Regulations capacities acknowledged progress while issuing recommendations.”
4cdc.govGovernment
https://www.cdc.gov/washington/testimony/2024/t20241114.htm
Backs: “CDC and other agencies have implemented lessons on testing, partnerships, and response frameworks.”
5axios.comNews and mediaquality 0.90
https://www.axios.com/2024/05/07/biodefense-buildup-urged-exclusive-report
Backs: “Gaps remain in integrating animal-human-environmental (One Health) surveillance and real-time data sharing.”
6stimson.orgNonprofits and think tanks
https://www.stimson.org/2024/prepare-for-the-next-biothreat-now/
Backs: “Funding is often reactive or subject to cuts/political shifts, risking “on-again/off-again” preparedness.”
7umn.eduAcademic
https://www.cidrap.umn.edu/smallpox/national-academies-report-says-us-not-ready-intentional-accidental-smallpox-outbreak
Backs: “A National Academies report highlighted unreadiness for a smallpox outbreak (intentional, accidental, or otherwise).”
8nejm.orgAcademic
https://www.nejm.org/doi/full/10.1056/NEJMp2406427
Backs: “H5N1 (avian influenza) circulation in US cattle has exposed coordination challenges between agriculture and health sectors, testing requirements, and farmer trust.”